Posts From November, 2017

LUMEDX Blog 

LUMEDX at RSNA 2017: Visit Booth 6235 for the latest in CV data intelligence

​Come see LUMEDX at the upcoming 103rd Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago and get the most up-to-date information about our cardiovascular service line and data intelligence tools.

RSNA 2017 will be held Nov. 26-Dec. 1 at the McCormick Convention Center. LUMEDX will be at Booth 6235, North—Hall B. The exhibition hall will be open 10 a.m. to 5 p.m. Nov. 26-29 and from 10 a.m. to 2 p.m. Nov. 30. About 25,000 attendees and 500 technical exhibitors are expected to attend the conference.

Learn more about our cardiovascular data intelligence offerings, which includes innovative software and services to help streamline care delivery, improve outcomes and dramatically reduce costs. Demos of LUMEDX’s powerful PACS and data management tools will also be available.

To schedule a meeting or demo, please click here.

Posted by Jana Ballinger Monday, November 20, 2017 10:27:00 AM Categories: analytics cardiology PACS

LUMEDX Blog 

Full-scale adoption of AI still a long way away, new study says

While the use of clinical and business intelligence tools is on the rise in healthcare, the hype surrounding artificial intelligence is unlikely to lead to full-scale adoption for quite some time, according to a new study by the Healthcare Information and Management Systems Society (HIMSS).

In the HIMSS 2017 Essentials Brief: Clinical and Business Intelligence, 23.5 percent of respondents said they expect their organizations to begin using AI within two years, 24.7 percent said within the next three to five years and 8.2 percent said six to 10 years. Only 4.7 percent said their organizations were already using AI and just 10.6 percent said they expect their organizations to begin leveraging AI within the next 12 months.

The prevailing belief seems to be that the technology just isn’t ready yet. Some 37 percent of respondents said further AI development is needed, 23.5 percent said the business case for AI was still unproven and 19.8 percent cited infrastructure constraints within their organizations. When questioned about barriers in the industry overall, 50 percent of respondents said they believe the technology is still in development and current opportunities to apply it to healthcare are difficult to understand.

Here are some of the other findings:

  • Clinical and Business Intelligence solution adoption rates for the U.S. healthcare market in 2017 are 48 percent and 62 percent, respectively.
  • Data governance, an important pre-requisite for the success of data analytics, has shown significant improvement in the “highly optimized” and “strong” categories from study respondents who were asked to qualify their efforts in this area.
  • While leveraging clinical analytics to meet Meaningful Use (MU) requirements and reporting remains the primary area of focus (nearly 70 percent of respondents), there has been an increase in the focus on population health year over year from roughly 20 percent in 2016 to 30 percent in 2017.

To learn more about the HIMSS findings, download the study here.

Clinical and financial business intelligence solutions have become essential to healthcare organizations in the move from volume to value-based care and in the development of new models of care. LUMEDX offers comprehensive, integrated cardiovascular data intelligence and imaging solutions—all with seamless connectivity to your enterprise systems (EHR/HIS).

For more information, download the Cardiovascular Performance Program Info Pack.

Posted by Jana Ballinger Monday, November 13, 2017 10:23:00 AM Categories: analytics data EHR HIMSS value-based purchasing
  • RSS

Statistics

  • Entries (224)
  • Comments (519)

Categories